Tâmara Natasha Gonzaga de Andrade Santos , Givalda Mendonça da Cruz Macieira , Kérilin Stancine Santos Rocha , Mônica Thais Ferreira Nascimento , Fernando de Castro Araújo Neto , Dyego Carlos Souza Anacleto de Araújo , Alessandra Rezende Mesquita , Divaldo Pereira de Lyra , Alfredo Dias de Oliveira Filho
{"title":"Content validation of drug problem-oriented clinical record","authors":"Tâmara Natasha Gonzaga de Andrade Santos , Givalda Mendonça da Cruz Macieira , Kérilin Stancine Santos Rocha , Mônica Thais Ferreira Nascimento , Fernando de Castro Araújo Neto , Dyego Carlos Souza Anacleto de Araújo , Alessandra Rezende Mesquita , Divaldo Pereira de Lyra , Alfredo Dias de Oliveira Filho","doi":"10.1016/j.sapharm.2025.01.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Worldwide, hospitals are responsible for restoring health. However, poorly executed processes in these institutions can lead to risks and harm to patients, especially in identifying drug related problems. This fact justifies the proposal of tools to support the diagnosis, management and resolution of these problems<strong>.</strong></div></div><div><h3>Objective</h3><div>To develop and content validate a clinical record that is oriented towards drug-related problems.</div></div><div><h3>Method</h3><div>A drug-oriented clinical record was first developed, after which it underwent content validation. The study was carried out between September and December 2017.7 The first version of the drug-related clinical record was prepared by two experienced researchers, using studies and problem-oriented medical tools described in the literature. Thereafter, content validation was performed using the nominal group technique. The expert panel consisted of a physician, two nurses, and three pharmacists with clinical experience in a hospital setting or pharmaceutical care. After that, the respective instrument was assessed according to the criteria objectivity, simplicity, clarity, relevance. These criteria are intended to ensure the rigor and reliability of instrument content.</div></div><div><h3>Results</h3><div>Experts’ suggestions included modification of the order of some items, insertion of new items, modification of item-writing procedures, expansion of specific fields, and better specification of data that is to be filled in as an item. The final version of the instrument was titled “DAM Clinical Record” (Diagnostics - Adverse Clinical Findings - Medicines) and comprised 45 items categorized into six sections: Patient Identification, Anamnesis, Clinical Diagnosis, Adverse Clinical Findings, Medicines and Pharmaceutical Evaluation.</div></div><div><h3>Conclusion</h3><div>A clinical record oriented towards drug-related problems, named DAM, was developed to guide healthcare professionals in identifying and solving drug-related problems. All relevant information generated in the hospital setting was consecutively stored as drug problem-oriented clinical records after undergoing thorough content validation.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"21 4","pages":"Pages 262-267"},"PeriodicalIF":3.7000,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Social & Administrative Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551741125000099","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Worldwide, hospitals are responsible for restoring health. However, poorly executed processes in these institutions can lead to risks and harm to patients, especially in identifying drug related problems. This fact justifies the proposal of tools to support the diagnosis, management and resolution of these problems.
Objective
To develop and content validate a clinical record that is oriented towards drug-related problems.
Method
A drug-oriented clinical record was first developed, after which it underwent content validation. The study was carried out between September and December 2017.7 The first version of the drug-related clinical record was prepared by two experienced researchers, using studies and problem-oriented medical tools described in the literature. Thereafter, content validation was performed using the nominal group technique. The expert panel consisted of a physician, two nurses, and three pharmacists with clinical experience in a hospital setting or pharmaceutical care. After that, the respective instrument was assessed according to the criteria objectivity, simplicity, clarity, relevance. These criteria are intended to ensure the rigor and reliability of instrument content.
Results
Experts’ suggestions included modification of the order of some items, insertion of new items, modification of item-writing procedures, expansion of specific fields, and better specification of data that is to be filled in as an item. The final version of the instrument was titled “DAM Clinical Record” (Diagnostics - Adverse Clinical Findings - Medicines) and comprised 45 items categorized into six sections: Patient Identification, Anamnesis, Clinical Diagnosis, Adverse Clinical Findings, Medicines and Pharmaceutical Evaluation.
Conclusion
A clinical record oriented towards drug-related problems, named DAM, was developed to guide healthcare professionals in identifying and solving drug-related problems. All relevant information generated in the hospital setting was consecutively stored as drug problem-oriented clinical records after undergoing thorough content validation.
期刊介绍:
Research in Social and Administrative Pharmacy (RSAP) is a quarterly publication featuring original scientific reports and comprehensive review articles in the social and administrative pharmaceutical sciences. Topics of interest include outcomes evaluation of products, programs, or services; pharmacoepidemiology; medication adherence; direct-to-consumer advertising of prescription medications; disease state management; health systems reform; drug marketing; medication distribution systems such as e-prescribing; web-based pharmaceutical/medical services; drug commerce and re-importation; and health professions workforce issues.